Leaflet SUMACTA 100mg film-coated tablets

Product code:
W59112004
Quantity:
6
Indicated for:
migraine
Route of administration:
oral
Substance:
sumatriptan (serotonin agonist antimigraine)
ATC
N02CC01 — Nervous system | Antimigraine preparations | Selective serotonin (5HT1) agonists

Precautions:

Breastfeeding warning

Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning

Pregnancy warning

Use during pregnancy only on medical advice.

Sumatriptan is a 5-HT1 receptor agonist used for the treatment of acute migraine and cluster headaches. It works by constricting blood vessels in the brain and reducing inflammation associated with migraines.

The medication is available in the form of tablets, injections, or nasal spray and should be taken as directed by a doctor, usually at the onset of migraine symptoms.

Patients should be aware of potential side effects, such as dizziness, nausea, or a sensation of pressure in the chest. It is important to inform the doctor of any unusual symptoms.

Common side effects include dizziness, nausea, fatigue, and tingling sensations. In rare cases, severe reactions such as high blood pressure or myocardial ischemia may occur. Patients should be informed of these risks before starting treatment.

General data about SUMACTA 100mg

Substance:
sumatriptan
Date of latest medicines list:
01-06-2026
Product code:
W59112004
Concentration:
100mg
Pharmaceutical form:
film-coated tablets
Quantity:
6
Product type:
Generic medicine
Price:
62.38 RON
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
ACTAVIS HF - ISLANDA
Holder:
ACTAVIS GROUP PTC EHF. - ISLANDA
Number:
4993/2012/04
Shelf life:
3 years

Concentrations available for sumatriptan

  • 100mg
  • 3mg/0.5ml
  • 50mg

Compensation lists for SUMACTA 100mg Actavis

A - Sublist A with 90% discount from the reference price

Price
62.38 RON
Copayment
56.14 RON
Patient
6.24 RON